FDA announces new rules about labeling of unit dose packages of drugs and vitamin supplements containing 30 mg or more of elemental iron. Safety Briefs FDA issues Public Health Advisory advising health professionals to monitor patients receiving low molecular weight heparins or heparinoids. FDA releases background article on the protease inhibitors. Nurse who administered oral medications intravenously is not prosecuted under criminal charges but has nursing license revoked. Gilead Sciences announces expanded access progran for investigationl, oral once-dail revers trnascriptase inhibitor, Preveon.
Generic name is nearly identical to another product.
Suggested to use Brand name when reffering to this drug. London, England pharmacist points out abbreviations in some counties are different and may cause confusion. An article on New York State Nurses Association web site claims that the Nursing Association has found a possible link between nurses who work in downsized facilities and the number of medication errors committed. APril 3,1998 seminar for pharmaceutical industry executives and other professional who work in marketing, legal, advertising, regulatory affairs and quality assurance. The purpose of the seminar, which will be held in Princeton, NJ, is to promote the development of safe pharmaceutical trademarks as well as safe pharmaceutical product labeling, packaging, and advertising.